New strategies for the treatment of early stages of Hodgkin's lymphoma.
The treatment of early or limited-stage Hodgkin's lymphoma continues to evolve. With the likelihood of cure of the lymphoma approaching 95% it has become increasingly necessary to balance improved effectiveness of treatment with minimization of troublesome late toxicity. Carefully crafted treatment strategies based on optimal combinations of brief chemotherapy and involved-field radiation or even reliance on brief chemotherapy alone for carefully selected patients have emerged as the most attractive approaches to achieve this important balance.
Macdonald
David A
DA
Division of Hematology, QEII Health Sciences Centre, Room 430, Bethune Building, 1278 Tower Road, Halifax, Nova Scotia B3H 2Y9, Canada.
Connors
Joseph M
JM
D000971:Antineoplastic Combined Chemotherapy Protocols; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant